Clinical trial

Efficacy and Safety Study of Bimatoprost Sustained-Release (SR) in Participants With Open-angle Glaucoma or Ocular Hypertension

NCT02247804

Study summary

ClinicalTrials.gov

Efficacy and Safety Study of Bimatoprost Sustained-Release (SR) in Participants With Open-angle Glaucoma or Ocular Hypertension

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Bimatoprost SR Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Active Comparator: Timolol 0.5% Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention Sham: Applicator Without Needle Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Timolol Vehicle (placebo) Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-12-15

PhasePHASE3

Conditions

Glaucoma, Open-Anglecandidate · MONDO: open-angle glaucoma

Ocular Hypertensionverified · MONDO: ocular hypertension

Interventions

Bimatoprost SRDRUG

Active Comparator: Timolol 0.5%DRUG

Sham: Applicator Without NeedleOTHER

Timolol Vehicle (placebo)DRUG

Sponsors & collaborators

Allerganlead sponsor

Mapped research locations

San AntonioTexas, United States3 BarcelonaSpain3 WarsawPoland3 HaifaIsrael3 São PauloBrazil2 Hong KongHong Kong2 New YorkNew York, United States1 HoustonTexas, United States1 ChicagoIllinois, United States1 Los AngelesCalifornia, United States1 PhiladelphiaPennsylvania, United States1 DallasTexas, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02247804 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.